{"slug":"api-magentlab-com-api-calc-ball-ce299e","title":"Soumerai 2019 BALL score for relapsed or refractory CLL","host":"api.magentlab.com","method":"POST","resource":"https://api.magentlab.com/api/calc/ball","category":"other","description":"Soumerai 2019 BALL score for relapsed or refractory CLL. Four caller-assigned 1-point flags (max 4): beta-2-microglobulin at the paper's published cutoff (>=5 mg/dL), LDH > laboratory ULN, anemia (Hb <110 g/L women or <120 g/L men), and time from initiation of last therapy <24 months. Risk low 0-1, ","price_listed":0.005,"price_asked":0.007,"state":"overcharges","state_label":"Asked 1.4x its listed price for its own example","checks_7d":1,"answered_7d":1,"latency_ms_median":261,"reported_calls_30d":0,"reported_payers_30d":0,"networks":["eip155:8453"],"badge":"unverified","paid_checks_7d":0,"paid_ok_7d":0,"example_input":{"body":{"items":[{"anemia":false,"b2m_ge_5":false,"last_therapy_lt_24mo":false,"ldh_gt_uln":false},{"anemia":false,"b2m_ge_5":false,"last_therapy_lt_24mo":false,"ldh_gt_uln":false}]},"method":"POST","type":"http"},"output_schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"anemia":{"description":"Anemia as assigned by the caller using Soumerai 2019 hemoglobin cutoffs (hemoglobin <110 g/L in women or <120 g/L in men). true or false. magent does not take a hemoglobin number or sex and does not assay hemoglobin.","type":"boolean"},"b2m_ge_5":{"description":"Serum β2-microglobulin at or above the Soumerai 2019 published cutoff (≥5 mg/dL) as assigned by the caller. true or false. magent does not assay B2M and does not convert mg/L versus mg/dL.","type":"boolean"},"last_therapy_lt_24mo":{"description":"Time from initiation of last therapy <24 months as assigned by the caller (Soumerai 2019). true or false. magent does not read a treatment calendar.","type":"boolean"},"ldh_gt_uln":{"description":"Serum LDH above the laboratory upper limit of normal as assigned by the caller (Soumerai 2019). true or false. magent does not assay LDH.","type":"boolean"}},"required":["b2m_ge_5","ldh_gt_uln","anemia","last_therapy_lt_24mo"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"},"history":[{"day":"2026-09-28","reachable":true,"status":402,"valid_402":true,"asked_usdc":0.007,"price_match":false,"latency_ms":261,"error":null}],"description_full":"Soumerai 2019 BALL score for relapsed or refractory CLL. Four caller-assigned 1-point flags (max 4): beta-2-microglobulin at the paper's published cutoff (>=5 mg/dL), LDH > laboratory ULN, anemia (Hb <110 g/L women or <120 g/L men), and time from initiation of last therapy <24 months. Risk low 0-1, intermediate 2-3, high 4. magent does not assay labs or convert B2M mg/L vs mg/dL. Not a treatment recommendation.","last_updated":"2026-09-28T15:08:15.517Z","schemes":["exact"]}